<qa>  What is the name of the DRUG that IS STUDIED IN PATIENTAN INVESTIGATIONAL DRUG, PF-02341066, IS BEING STUDIED IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER WITH A SPECIFIC GENE PROFILE INVOLVING THE ANAPLASTIC LYMPHOMA KINASE ALK GENE: 